Comments
Loading...

Purple Biotech

PPBTNASDAQ
Logo brought to you by Benzinga Data
$7.11
0.010.14%
Pre-Market: 4:54 PM EDT
15 minutes delayed
Purple Biotech Ltd is expected to split Tuesday, September 17, 2024 with a ratio of 1:20
Consensus Rating1
Buy
Highest Price Target1
$11.00
Lowest Price Target1
$8.00
Consensus Price Target1
$9.50

Purple Biotech (NASDAQ:PPBT) Stock, Analyst Ratings, Price Targets, Forecasts

Purple Biotech Ltd has a consensus price target of $9.5 based on the ratings of 4 analysts. The high is $11 issued by Chardan Capital on March 7, 2024. The low is $8 issued by HC Wainwright & Co. on August 19, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on August 19, 2024, July 11, 2024, and May 21, 2024, respectively. With an average price target of $9.33 between HC Wainwright & Co., there's an implied 31.27% upside for Purple Biotech Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Jul
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Chardan Capital
JonesTrading
Chardan Capital

1calculated from analyst ratings

Analyst Ratings for Purple Biotech

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Purple Biotech (PPBT) stock?

A

The latest price target for Purple Biotech (NASDAQ:PPBT) was reported by HC Wainwright & Co. on August 19, 2024. The analyst firm set a price target for $8.00 expecting PPBT to rise to within 12 months (a possible 12.52% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Purple Biotech (PPBT)?

A

The latest analyst rating for Purple Biotech (NASDAQ:PPBT) was provided by HC Wainwright & Co., and Purple Biotech maintained their buy rating.

Q

When was the last upgrade for Purple Biotech (PPBT)?

A

There is no last upgrade for Purple Biotech

Q

When was the last downgrade for Purple Biotech (PPBT)?

A

There is no last downgrade for Purple Biotech.

Q

When is the next analyst rating going to be posted or updated for Purple Biotech (PPBT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Purple Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Purple Biotech was filed on August 19, 2024 so you should expect the next rating to be made available sometime around August 19, 2025.

Q

Is the Analyst Rating Purple Biotech (PPBT) correct?

A

While ratings are subjective and will change, the latest Purple Biotech (PPBT) rating was a maintained with a price target of $10.00 to $8.00. The current price Purple Biotech (PPBT) is trading at is $7.11, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch